S13 CV Risk in Diabetes: Emerging Suspects

Program: Symposia
Clinical/Translational Session
Thursday, March 5, 2015: 4:30 PM-6:00 PM
Room 30A (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Merck & Co., Inc.

Peter D Reaven, MD, University of Arizona, ,

Nothing to Disclose: PDR
4:30 PM
Rodica Pop Busui, MD, PhD, Internal Medicine/Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI
Disclosure: RPB: Ad Hoc Consultant, Astra Zeneca, Investigator, Bristol-Myers Squibb, Ad Hoc Consultant, Accorda Therapeutics.
5:00 PM
Abd A Tahrani, MD, MRCP (UK), MMedSci, CCT (Endocrinology), PhD, Centre of Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, United Kingdom
Nothing to Disclose: AAT
5:30 PM
Stephen Neil Davis, MBBS, Medicine, University of Maryland School of Medicine, Baltimore, MD
Nothing to Disclose: SND
See more of: Symposia